CORE RESEARCH GROUPS

Cancer Biology

This group identifies targets to inhibit tumor growth and cell proliferation. The group focuses on tumor growth related to neurological cancer, melanoma and lung cancer, colon cancer, prostate cancer, and breast cancer.

Group Director:
Candace L Johnson, Ph.D.
Senior VP of Translational Research
Pharmacology and Therapeutics
Roswell Park Cancer Institute

 

 

 

 

 

Cardiovascular Disease

This group conducts animal and human research related to cardiovascular disease areas such as heart failure and sudden death.

Group Director:
John Canty, M.D.
Albert & Elizabeth Rekate Chair in Cardiovascular Disease
School of Medicine and Biomedical Sciences
University at Buffalo

 

 

 

Developmental Genomics

This group is dedicated to understanding fundamental developmental and disease processes by the analysis of gene expression patterns and genetic perturbation of model organisms.

Group Directors: Richard Gronostajski, Ph.D. Professor of Biochemistry in the School of Medicine and Biomedical Sciences at the University at Buffalo..	Satrajit Sinha, Ph.D.        Associate Professor of Biochemistry at the University at Buffalo, School of Medicine and Biomedical Sciences
Marc Halfon, Ph.D. Assistant Professor in the Department of Biochemistry at the New York State Center of Excellence in Bioinformatics and Life Science.	Michael Buck, Ph.D. Assistant Professor of Biochemistry at the New York State Center of Excellence in Bioinformatics and Life Sciences.
Lee Ann Garrett Sinha, Ph.D. Assistant Professor of Biochemistry in the School of Medicine and Biomedical Sciences at the University at Buffalo.

 

 

 

 

 

Informatics and Ontology

This group develops powerful tools for information integration and reasoning in all domains of clinical and translational research, including clinical trial data management and electronic health records.

Group Directors: Barry Smith, Ph.D. SUNY Distinguished Professor of Philosophy and Director of the National Center for Ontological Research, University at Buffalo	Werner Ceusters, M.D. Professor of Health Sciences and Coordinator of Bioinformatics for the UB Health Science Faculties, University at Buffalo
Louis J. Goldberg, Ph.D. Professor in the Department of Oral Diagnostic Sciences and Dean Emeritus of the UB School of Dental Medicine, University at Buffalo

 

 

Neurodegenerative Disease

This group investigates disease mechanisms of several neurological disorders, including Alzheimer's Disease, Multiple Sclerosis, Krabbe's Disease, Parkinson's Disease, and Neurovascular Diseases.

Group Directors: Jian Feng, Ph.D. Associate Professor Physiology and Biophysics School of Medicine and Biomedical Sciences University at Buffalo

Zhen Yan, Ph.D. Associate Professor Physiology and Biophysics School of Medicine and Biomedical Sciences University at Buffalo

 

 

Pathogens and Biodefense

This group investigates virulence factors for bacteria and viruses important in human disease and in biodefense.

Group Directors: Steven Gill, Ph.D. Associate Professor Oral Biology School of Dental Medicine University at Buffalo	John Hay, Ph.D. Grant T. Fisher Chair & Professor of Microbiology & Immunology University at Buffalo
Anthony Campagnari, Ph.D. Professor of Microbiology & Immunology University at Buffalo	Thomas Russo, MD Professor of Medicine University at Buffalo

 

 

 

Translational Pharmacology

This group will foster innovative translational pharmacology research in the areas of drug development, applied translational pharmacology, clinical pharmacology and pharmacogenomics and proteomics with an emphasis in oncology, neurology, infectious diseases and inflammation and cardiovascular disease.

[About the Translational Pharmacology Core]

Group Director:
Gene D. Morse, Pharm.D.
Professor and Chairman of Pharmacy Practice
Associate Dean, Clinical Education and Research
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo

 

News

Buffalo Niagara Medical Campus to Revamp Trico Site
07/19/2008 - BUFFALO, N.Y. -- Armed with a $4.5 million cash transfusion, the Buffalo Niagara Medical Campus is pushing ahead with a key physical expansion.  Patrick Whelan, BNMC chief operating officer, said funding approved last week by the Empire State Development Corp. will aid a $12 million effort to turn a portion of the former Trico windshield wiper plant into a high-tech innovation center...[Read On...]

Quantum Rod System May Safely 'Sneak' Drugs, Diagnostics into Brain
07/16/2008 - BUFFALO, N.Y. -- A unique nanoparticle system developed by University at Buffalo scientists takes advantage of the versatility of bioconjugated quantum rods to ferry novel diagnostic and therapeutic agents across the blood-brain barrier, according to recent in vitro findings. Described in a paper published in Bioconjugate Chemistry, the system uses the rod-shaped semiconductor nanoparticles that are bioconjugated, or coupled, with biomolecules capable of crossing the blood-brain barrier...[Read On...]

Visit the News Archive

Events

September 23, 2008 - MedTech08 Biosciences Summit
Growing, Changing, Booming: Adapting healthcare to the needs of an aging population.  Join us at The Lodge in Skaneateles NY for this exciting daylong event packed with industry leaders sharing their strategies for successfully adapting to the aging boomer demographic.  To learn more and register, Click here

October 27-28, 2008 - AACR Centennial Symposium
Roswell Park Cancer Institute is hosting the American Association for Cancer Research (AACR) Centennial Symposium, entitled “The Future of Cancer Research: Science and Patient Impact”, this fall.  To learn more and register, Click here.

To view the complete list of events and event details, please visit our Events page

To receive periodic News & Events emails from the COE, please join our mailing list!